relapsed or refractory B-cell precursor acute lymphoblastic leukemia | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

166,519 results for “relapsed or refractory B-cell precursor acute lymphoblastic leukemia”

Trials

View all 125463 →

Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)

207 participants · First posted Dec 1, 2014

Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL

17 participants · First posted Aug 24, 2020

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

80 participants · First posted Oct 4, 2012

Drugs

View all 7375 →

AM E3-SG-3249

4SCAR19U T cell therapy (B-cell acute lymphoblastic leukemia/B-cell lymphoma)

MLLT1/3 inhibitors (acute lymphoblastic leukemia/acute myelogenous leukemia)

Organizations

View all 3328 →

Nkarta

United States

CARGO Therapeutics

United States

Cardiff Oncology

United States

News

View all 30353 →

FDA Approves Autolus's AUCATZYL (obecabtagene autoleucel) CAR-T Therapy for Adult ALL

FDA Approves Obecabtagene Autoleucel (Obe-cel) for Relapsed/Refractory B-Cell ALL

FDA Approves Aucatzyl (obecabtagene autoleucel) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Page 1 of 16652